Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M, Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer, «CANCER», 2006, 107, pp. 2842 - 2849 [Comment or similar]
Bozzetti C; Musolino A; Camisa R; Bisagni G; Flora M; Bassano C; Martella E; Lagrasta C; Nizzoli R; Personeni N; Leonardi F; Cocconi G; Ardizzoni A, Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer - The role of anthrocycline dose intensity, «AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS», 2006, 29, pp. 171 - 177 [Comment or similar]
Scartozzi M; Franciosi V; Campanini N; Benedetti G; Barbieri F; Rossi G; Berardi R; Camisa R; Silva RR; Santineelli A; Ardizzoni A; Crino L; Rindi G; Cascinu S, Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients, «LUNG CANCER», 2006, 53, pp. 103 - 109 [Comment or similar]
Tiseo M; Franciosi V; Ardizzoni A, Multi-target inhibitors in non-small cell lung cancer (NSCLC), «ANNALS OF ONCOLOGY», 2006, 17, pp. 55 - 57 [Comment or similar]
Ardizzoni A; Tiseo M, Novel targeted approaches in non-small cell lung cancer (NSCLC), «ANNALS OF ONCOLOGY», 2006, 17, pp. V91 - V93 [Comment or similar]
Musolino A; Naldi N; Michiara M; Bella MA; Zanelli P; Bortesi B; Capelletti M; Savi M; Neri TM; Ardizzoni A, A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes, «BREAST CANCER RESEARCH AND TREATMENT», 2005, 91, pp. 203 - 205 [Comment or similar]
Scagliotti GV; Smit E; Bosquee L; O'Brien M; Ardizzoni A; Zatloukal P; Eberhardt W; Smid-Geirnaerdt M; de Bruin HG; Dussenne S; Legrand C; Giaccone G, A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956), «LUNG CANCER», 2005, 50, pp. 91 - 96 [Comment or similar]
Tiseo M; Monetti E; Ferrarini M; Serrano J; Chiaramondia M; Ardizzoni A, Dramatic responses to therapy in rare tumors, «JOURNAL OF CLINICAL ONCOLOGY», 2005, 23, pp. 1578 - 1579 [Comment or similar]
Loprevite M; Tiseo M; Grossi F; Scolaro T; Semino C; Pandolfi A; Favoni R; Ardizzoni A, In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines, «ONCOLOGY RESEARCH», 2005, 15, pp. 39 - 48 [Comment or similar]
Ardizzoni A; Scolaro T; Mereu C; Cafferata MA; Tixi L; Bacigalupo A; Tiseo M; Monetti F; Rosso R, Induction chemotherapy with carboplatin-paclitaxel followed by standard radiotherapy with concurrent daily low-dose cisplatin plus weekly paclitaxel for inoperable non-small-cell lung cancer, «AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS», 2005, 28, pp. 58 - 64 [Comment or similar]
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G, Lomustine (Chloroethyinitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma, «CANCER», 2005, 103, pp. 2109 - 2117 [Comment or similar]
MUSOLINO A; BOZZETTI C; BONOMINI S; SAMMARELLI G; PEZZUOLO D; BONATI A; ARDIZZONI A, Lung cancer in patients with chronic lymphocytic leukemia: does the HER-2 oncogene play a role?, «LUNG CANCER», 2005, 50, pp. 419 - 420 [Comment or similar]
Musolino A; Michiara M; Bella MA; Naldi N; Zanelli P; Bortesi B; Capelletti M; Soldani L; Camisa R; Martella E; Franciosi V; Savi M; Neri TM; Ardizzoni A; Cascinu S, Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study, «TUMORI», 2005, 91, pp. 505 - 512 [Comment or similar]
Trombino S; Neri M; Puntoni R; Angelini C; Loprevite M; Cesario A; Granone P; Imperatori A; Dominioni L; Ardizzoni A; Filiberti R; Russo P, Mutations in K-ras codon 12 detected in plasma DNA are not an indicator of disease in patients with non-small cell lung cancer, «CLINICAL CHEMISTRY», 2005, 51, pp. 1313 - 1314 [Comment or similar]
Tiseo M; Boni L; Ardizzoni A, Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: Does cisplatin versus carboplatin make a difference?, «JOURNAL OF CLINICAL ONCOLOGY», 2005, 23, pp. 6276 - 6277 [Comment or similar]
